CN105316113A - Polyunsaturated fatty acid enriching method - Google Patents
Polyunsaturated fatty acid enriching method Download PDFInfo
- Publication number
- CN105316113A CN105316113A CN201510196920.XA CN201510196920A CN105316113A CN 105316113 A CN105316113 A CN 105316113A CN 201510196920 A CN201510196920 A CN 201510196920A CN 105316113 A CN105316113 A CN 105316113A
- Authority
- CN
- China
- Prior art keywords
- fatty acid
- polyunsaturated fatty
- crystallization
- content
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 title claims abstract description 38
- 238000000034 method Methods 0.000 title claims abstract description 15
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims abstract description 44
- 238000002425 crystallisation Methods 0.000 claims abstract description 40
- 230000008025 crystallization Effects 0.000 claims abstract description 39
- 239000002904 solvent Substances 0.000 claims abstract description 19
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 18
- 229930195729 fatty acid Natural products 0.000 claims abstract description 18
- 239000000194 fatty acid Substances 0.000 claims abstract description 18
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 18
- 235000021323 fish oil Nutrition 0.000 claims abstract description 12
- 239000002994 raw material Substances 0.000 claims abstract description 11
- 235000019198 oils Nutrition 0.000 claims abstract description 10
- 230000000813 microbial effect Effects 0.000 claims abstract description 6
- 239000006227 byproduct Substances 0.000 claims abstract description 5
- MBMBGCFOFBJSGT-KUBAVDMBSA-N docosahexaenoic acid Natural products CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims description 13
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 claims description 10
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 claims description 8
- 235000020673 eicosapentaenoic acid Nutrition 0.000 claims description 8
- 229960005135 eicosapentaenoic acid Drugs 0.000 claims description 8
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 4
- 235000020660 omega-3 fatty acid Nutrition 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims 5
- 150000002632 lipids Chemical class 0.000 claims 5
- PIFPCDRPHCQLSJ-WYIJOVFWSA-N 4,8,12,15,19-Docosapentaenoic acid Chemical compound CC\C=C\CC\C=C\C\C=C\CC\C=C\CC\C=C\CCC(O)=O PIFPCDRPHCQLSJ-WYIJOVFWSA-N 0.000 claims 2
- PIFPCDRPHCQLSJ-UHFFFAOYSA-N Clupanodonic acid Natural products CCC=CCCC=CCC=CCCC=CCCC=CCCC(O)=O PIFPCDRPHCQLSJ-UHFFFAOYSA-N 0.000 claims 2
- 235000021290 n-3 DPA Nutrition 0.000 claims 2
- HXWJFEZDFPRLBG-UHFFFAOYSA-N Timnodonic acid Natural products CCCC=CC=CCC=CCC=CCC=CCCCC(O)=O HXWJFEZDFPRLBG-UHFFFAOYSA-N 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- DVSZKTAMJJTWFG-UHFFFAOYSA-N docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCCC=CC=CC=CC=CC=CC=CC(O)=O DVSZKTAMJJTWFG-UHFFFAOYSA-N 0.000 claims 1
- IQLUYYHUNSSHIY-HZUMYPAESA-N eicosatetraenoic acid Chemical compound CCCCCCCCCCC\C=C\C=C\C=C\C=C\C(O)=O IQLUYYHUNSSHIY-HZUMYPAESA-N 0.000 claims 1
- 238000001953 recrystallisation Methods 0.000 claims 1
- 239000003921 oil Substances 0.000 abstract description 9
- 239000007791 liquid phase Substances 0.000 abstract description 8
- 238000000926 separation method Methods 0.000 abstract description 8
- 239000007788 liquid Substances 0.000 abstract description 6
- 238000002360 preparation method Methods 0.000 abstract description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 abstract description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 abstract description 2
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 7
- 229940090949 docosahexaenoic acid Drugs 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- 229940114079 arachidonic acid Drugs 0.000 description 4
- 235000021342 arachidonic acid Nutrition 0.000 description 4
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 description 2
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 210000000133 brain stem Anatomy 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 235000018823 dietary intake Nutrition 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- XTLNYNMNUCLWEZ-UHFFFAOYSA-N ethanol;propan-2-one Chemical compound CCO.CC(C)=O XTLNYNMNUCLWEZ-UHFFFAOYSA-N 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 235000021085 polyunsaturated fats Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Landscapes
- Fats And Perfumes (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
本发明公开了一种多不饱和脂肪酸的富集方法,利用乙腈作为结晶溶剂,对来自于鱼油、鱼油副产物、微生物油脂的脂肪酸原料进行一次或多次结晶与分离操作,富集其中的多不饱和脂肪酸。包括以下步骤:(1)脂肪酸与一定体积乙腈混合均匀,置于低温下结晶,结晶后进行固液分离,液相中多不饱和脂肪酸含量可提高至50%~90%,产率达到50%以上;(2)若需进一步提高多不饱和脂肪酸的含量,可将(1)中液相除去部分溶剂,进行多次低温结晶,多不饱和脂肪酸含量可提高至80%以上。本发明的方法操作简单,溶剂可循环使用,较其他溶剂低温结晶省时,多不饱和脂肪酸含量和产率提高较多,可应用于多不饱和脂肪酸医药原料的制备。The invention discloses a method for enriching polyunsaturated fatty acids. Acetonitrile is used as a crystallization solvent to carry out one or more crystallization and separation operations on fatty acid raw materials from fish oil, fish oil by-products, and microbial oils to enrich polyunsaturated fatty acids. unsaturated fatty acid. The method comprises the following steps: (1) the fatty acid is uniformly mixed with a certain volume of acetonitrile, crystallized at a low temperature, solid-liquid separation is carried out after the crystallization, the content of the polyunsaturated fatty acid in the liquid phase can be increased to 50%-90%, and the yield can reach 50%. Above; (2) if the content of polyunsaturated fatty acids needs to be further improved, part of the solvent can be removed from the liquid phase in (1), and multiple low-temperature crystallizations can be carried out, so that the content of polyunsaturated fatty acids can be increased to more than 80%. The method of the invention is simple to operate, the solvent can be recycled, time-saving compared with other solvents for low-temperature crystallization, the polyunsaturated fatty acid content and yield are greatly improved, and can be applied to the preparation of polyunsaturated fatty acid pharmaceutical raw materials.
Description
技术领域technical field
本发明涉及一种多不饱和脂肪酸的富集方法,更具体的说,是一种多不饱和脂肪酸的溶剂结晶富集方法。The invention relates to a method for enriching polyunsaturated fatty acids, more specifically, a method for enriching polyunsaturated fatty acids through solvent crystallization.
背景技术Background technique
多不饱和脂肪酸在人体营养和疾病预防方面的重要作用已经被科学界公认。很多研究都报道了多不饱和脂肪酸益于健康的作用。其中二十碳四烯酸(ARA)和二十二碳六烯酸(DHA)不仅是神经膜系统的重要组成成分,还是母乳中的天然脂肪酸,对于婴幼儿的大脑和神经系统的生长具有重要作用。二十碳五烯酸(EPA)和二十二碳六烯酸(DHA)对于心血管疾病、动脉粥样硬化、慢性炎症、老年痴呆症都具有很好的预防和治疗作用。由于人体不能直接合成或合成较少的ω-3和ω-6多不饱和脂肪,所以必须通过饮食来摄入补充。The important role of polyunsaturated fatty acids in human nutrition and disease prevention has been recognized by the scientific community. Numerous studies have reported the health benefits of polyunsaturated fatty acids. Among them, arachidonic acid (ARA) and docosahexaenoic acid (DHA) are not only important components of the neuromembrane system, but also natural fatty acids in breast milk, which are important for the growth of the brain and nervous system of infants. effect. Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) have good preventive and therapeutic effects on cardiovascular diseases, atherosclerosis, chronic inflammation, and Alzheimer's disease. Since the body cannot directly synthesize or synthesize less omega-3 and omega-6 polyunsaturated fats, they must be supplemented through dietary intake.
天然油脂中的多不饱和脂肪酸含量较低,若需要达到一定保健功效或药用功效则需要纯度较高的多不饱和脂肪酸。故需要对多不饱和脂肪酸进行富集。低温结晶主要是利用不同脂肪酸在不同温度及不同溶剂中溶解度的差异来进行分离。这种溶解度的差异取决于脂肪酸的链长度和双键数。当脂肪酸中双键数目相同时,碳链越长其溶解度越低;当碳链长度一定时,双键数目越多其溶解度越大。低温结晶操作简单,成本低廉,溶剂可回收使用。The content of polyunsaturated fatty acids in natural oils and fats is relatively low, and polyunsaturated fatty acids with higher purity are required to achieve certain health effects or medicinal effects. Therefore, it is necessary to enrich polyunsaturated fatty acids. Low-temperature crystallization mainly uses the difference in solubility of different fatty acids at different temperatures and in different solvents to separate them. This difference in solubility depends on the chain length and number of double bonds of the fatty acid. When the number of double bonds in the fatty acid is the same, the longer the carbon chain, the lower the solubility; when the length of the carbon chain is constant, the more the number of double bonds, the greater the solubility. Low-temperature crystallization is easy to operate, low in cost, and the solvent can be recycled.
李和等利用丙酮-乙醇混合溶剂,通过控制结晶速率,对鱼油脂肪酸中的EPA和DHA进行富集,经过一次分离含量由7%~15%提高至50%~58%,经过两次分离可达到73%~79%(李和,李佩文等.低温结晶富集鱼油中EPA与DHA的方法。《中国华阳药物》,1997,4:50-52)。李鹏程等将海洋动物油脂型下脚料粉提取油脂后,利用1~3倍丙酮在-80~0℃下放置6~12h后进行固液分离富集EPA和DHA的含量(李鹏程,李婷等.一种提取天然EPA和DHA的方法.中国,201410015950.1)。传统的溶剂低温结晶多采用丙酮或正己烷作为低温结晶溶剂,耗时较多,一般需要在低温下结晶10h以上,降低了富集效率。本发明应用乙腈作为低温结晶溶剂,大大缩短结晶所需时间,保留了低温结晶操作的优点,且可较显著地提高多不饱和脂肪酸的纯度及产率,适合于工业生产。Li He et al. used acetone-ethanol mixed solvents to enrich EPA and DHA in fish oil fatty acids by controlling the crystallization rate. After one separation, the content increased from 7% to 15% to 50% to 58%. Reach 73% to 79% (Li He, Li Peiwen et al. Low-temperature crystallization method for enriching EPA and DHA in fish oil. "China Huayang Medicine", 1997, 4: 50-52). After Li Pengcheng et al. extracted the oil from the marine animal oil-type waste powder, they used 1 to 3 times acetone to place it at -80-0°C for 6-12 hours, and then carried out solid-liquid separation to enrich the content of EPA and DHA (Li Pengcheng, Li Ting et al. A method for extracting natural EPA and DHA. China, 201410015950.1). Traditional solvent low-temperature crystallization mostly uses acetone or n-hexane as the low-temperature crystallization solvent, which takes a lot of time. Generally, it needs to be crystallized at low temperature for more than 10 hours, which reduces the enrichment efficiency. The invention uses acetonitrile as a low-temperature crystallization solvent, greatly shortens the time required for crystallization, retains the advantages of low-temperature crystallization operations, and can significantly improve the purity and yield of polyunsaturated fatty acids, which is suitable for industrial production.
发明内容Contents of the invention
本发明的目的:利用乙腈作为溶剂,对来自于鱼油、鱼油副产物、微生物油脂的脂肪酸进行一次或多次结晶与分离操作,富集其中的多不饱和脂肪酸。The purpose of the present invention is to use acetonitrile as a solvent to carry out one or more crystallization and separation operations on fatty acids from fish oil, fish oil by-products, and microbial oils to enrich the polyunsaturated fatty acids therein.
本发明的技术方案:以来自于鱼油、鱼油副产物、微生物油脂的脂肪酸为原料,与一定量乙腈充分混合后进行一次或多次低温结晶富集多不饱和脂肪酸。具体步骤为:The technical solution of the present invention is to use fatty acids from fish oil, fish oil by-products and microbial oils as raw materials, fully mix them with a certain amount of acetonitrile, and carry out one or more low-temperature crystallization to enrich polyunsaturated fatty acids. The specific steps are:
(1)一次低温结晶(1) Primary low temperature crystallization
将来自于鱼油、鱼油副产物、微生物油脂的脂肪酸与乙腈按1∶5~1∶25(W/V)比例混合均匀,置于-80~0℃下低温结晶0.5~2h,结晶后进行固液分离,收集液相于45℃真空下脱除溶剂。经过第一次低温结晶,原料多不饱和脂肪酸含量可提高至60%~90%,实际产率达到55%~75%。Mix fatty acids from fish oil, fish oil by-products, and microbial oils with acetonitrile evenly at a ratio of 1:5 to 1:25 (W/V), place them at -80 to 0°C for low temperature crystallization for 0.5 to 2 hours, and carry out solidification after crystallization. The liquid was separated, and the liquid phase was collected and the solvent was removed under vacuum at 45°C. After the first low-temperature crystallization, the polyunsaturated fatty acid content of the raw material can be increased to 60%-90%, and the actual yield can reach 55%-75%.
(2)多次低温结晶(2) multiple low temperature crystallization
若需要进一步提高多不饱和脂肪酸的含量,可将上一步结晶后的液相除去1/3~1/2的溶剂,继续置于-80~-40℃下结晶0.5~1h,可进一步使多不饱和脂肪酸含量提高至90%~96%。If it is necessary to further increase the content of polyunsaturated fatty acids, 1/3~1/2 of the solvent can be removed from the liquid phase after crystallization in the previous step, and the crystallization can be continued at -80~-40°C for 0.5~1h, and the polyunsaturated fatty acids can be further made Unsaturated fatty acid content increased to 90% to 96%.
本发明操作简单,成本低廉,较为省时,且溶剂可回收循环使用。整个操作过程中条件温和,不会对多不饱和脂肪酸结构产生破坏,且得到的产品多不饱和脂肪酸纯度和产率较高,可应用于医药工业前期原料的制备。The invention has the advantages of simple operation, low cost and time saving, and the solvent can be recycled and used. The conditions in the whole operation process are mild, the structure of the polyunsaturated fatty acid will not be damaged, and the purity and yield of the obtained polyunsaturated fatty acid are high, which can be applied to the preparation of raw materials in the early stage of the pharmaceutical industry.
具体实施方式detailed description
为了更好地阐述本发明的内容,下面结合具体的实例对本发明作进一步说明,并且本发明的保护范围不仅局限于以下实施实例。In order to better illustrate the content of the present invention, the present invention will be further described below in conjunction with specific examples, and the protection scope of the present invention is not limited to the following examples.
实施方案一Implementation plan one
取藻油脂肪酸50g,将其与400ml乙腈在室温下混合均匀,置于-40℃冰箱中低温结晶1.5h。待结晶完成后,进行固液分离,取其液相在45℃下去除乙腈得所需产品。用气相分原料及产品脂肪酸组成,并计算相应产率,如下表所示:Take 50 g of algal oil fatty acid, mix it with 400 ml of acetonitrile at room temperature, and place it in a -40°C refrigerator for low-temperature crystallization for 1.5 h. After the crystallization is completed, the solid-liquid separation is carried out, and the liquid phase is taken to remove acetonitrile at 45° C. to obtain the desired product. Use the gas phase to separate the fatty acid composition of raw materials and products, and calculate the corresponding yield, as shown in the table below:
表1原料、产品多不饱和脂肪酸组成Table 1 raw material, product polyunsaturated fatty acid composition
通过一次结晶,可使藻油多不饱和脂肪酸含量由57.82%提升至90.54%,产率达到59.76%。其中DPA(ω-6)由16.38%提高至24.59%,DHA由38.92%提高至61.83%。Through one crystallization, the polyunsaturated fatty acid content of algae oil can be increased from 57.82% to 90.54%, and the yield can reach 59.76%. Among them, DPA (omega-6) increased from 16.38% to 24.59%, and DHA increased from 38.92% to 61.83%.
实施方案二Implementation plan two
取50g金枪鱼油脂肪酸,与550ml乙腈在室温下混合均匀,将脂肪酸-乙腈溶液置于-40℃冰箱中1h,进行第一次低温结晶。待结晶完成后,进行固液分离,取其液相,在-45℃真空下除去1/2溶剂,将新的脂肪酸-乙腈溶液置于-80℃冰箱中进行第二次结晶0.5h。待结晶完成后,进行第二次固液分离,将液相部分45℃真空下除去乙腈得产品。用气相分析原料及产品脂肪酸组成,实验结果如下表所示:Take 50g tuna oil fatty acid and mix it with 550ml acetonitrile evenly at room temperature, put the fatty acid-acetonitrile solution in a -40°C refrigerator for 1 hour to perform the first low-temperature crystallization. After the crystallization is complete, solid-liquid separation is carried out, and the liquid phase is taken, and 1/2 of the solvent is removed under vacuum at -45°C, and the new fatty acid-acetonitrile solution is placed in a -80°C refrigerator for the second crystallization for 0.5h. After the crystallization is completed, the second solid-liquid separation is carried out, and the liquid phase is removed from the acetonitrile under vacuum at 45°C to obtain the product. The fatty acid composition of raw materials and products was analyzed by gas phase, and the experimental results are shown in the table below:
表2原料、产品脂肪酸组成及产率Table 2 Raw materials, product fatty acid composition and yield
通过二次结晶,使金枪鱼油多不饱和脂肪酸由37.67%提高至89.36%。其中EPA由6.71%提高至16.47%,DHA由25.70%提高至65.33%。Through secondary crystallization, the polyunsaturated fatty acid of tuna oil is increased from 37.67% to 89.36%. Among them, EPA increased from 6.71% to 16.47%, and DHA increased from 25.70% to 65.33%.
实施方案三Implementation plan three
取10g富含ARA的微生物油脂脂肪酸(其中饱和脂肪酸含量30%左右,单不饱和脂肪酸含量10%左右,C18:2和C18:3含量在17%左右,C20:4含量在40%左右)与100ml乙腈充分混合,置于-20℃下低温结晶1h后,除去固相,将液相中溶剂乙腈去除得到产品。产品中ARA含量达到70%,产率为60%。Take 10g of microbial fatty acids rich in ARA (the content of saturated fatty acid is about 30%, the content of monounsaturated fatty acid is about 10%, the content of C18:2 and C18:3 is about 17%, and the content of C20:4 is about 40%) and 100ml of acetonitrile was mixed thoroughly, placed at -20°C for low-temperature crystallization for 1 hour, the solid phase was removed, and the solvent acetonitrile in the liquid phase was removed to obtain the product. The ARA content in the product reaches 70%, and the yield is 60%.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510196920.XA CN105316113A (en) | 2015-04-21 | 2015-04-21 | Polyunsaturated fatty acid enriching method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510196920.XA CN105316113A (en) | 2015-04-21 | 2015-04-21 | Polyunsaturated fatty acid enriching method |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105316113A true CN105316113A (en) | 2016-02-10 |
Family
ID=55244442
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510196920.XA Pending CN105316113A (en) | 2015-04-21 | 2015-04-21 | Polyunsaturated fatty acid enriching method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105316113A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107418724A (en) * | 2017-04-19 | 2017-12-01 | 天津大学 | A kind of method for separating unsaturated fat acid blend in soybean oil residue aliphatic acid |
CN107602386A (en) * | 2017-08-28 | 2018-01-19 | 浙江海洋大学 | A kind of method that low temperature crystallization is enriched with ethyl esterified fish oil EPA, DHA |
WO2018071553A1 (en) * | 2016-10-11 | 2018-04-19 | Ingevity South Carolina, Llc | Method of separating tall oil fatty acids |
CN111575110A (en) * | 2020-05-27 | 2020-08-25 | 嘉必优生物技术(武汉)股份有限公司 | A kind of purification method of microbial oil containing polyunsaturated fatty acid |
CN115715559A (en) * | 2022-11-08 | 2023-02-28 | 嘉必优生物技术(武汉)股份有限公司 | Method for enriching DHA in grease |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1986515A (en) * | 2006-12-30 | 2007-06-27 | 中国人民解放军总医院 | Process of extracting omega-3 polyunsaturated fatty acid from turtle oil |
CN101099514A (en) * | 2007-04-09 | 2008-01-09 | 李赤翎 | Semen trichosanthis health care oil and its separating technology |
CN101353612A (en) * | 2008-08-22 | 2009-01-28 | 中南林业科技大学 | A method for enriching polyunsaturated fatty acids from pine caterpillars |
CN101805670A (en) * | 2010-04-09 | 2010-08-18 | 上海中器环保科技有限公司 | Preparation method of microbial diesel |
CN101892119A (en) * | 2010-06-29 | 2010-11-24 | 陕西师范大学 | Gradient freeze crystallization method for polyunsaturated fatty acids from silkworm chrysalis oil |
-
2015
- 2015-04-21 CN CN201510196920.XA patent/CN105316113A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1986515A (en) * | 2006-12-30 | 2007-06-27 | 中国人民解放军总医院 | Process of extracting omega-3 polyunsaturated fatty acid from turtle oil |
CN101099514A (en) * | 2007-04-09 | 2008-01-09 | 李赤翎 | Semen trichosanthis health care oil and its separating technology |
CN101353612A (en) * | 2008-08-22 | 2009-01-28 | 中南林业科技大学 | A method for enriching polyunsaturated fatty acids from pine caterpillars |
CN101805670A (en) * | 2010-04-09 | 2010-08-18 | 上海中器环保科技有限公司 | Preparation method of microbial diesel |
CN101892119A (en) * | 2010-06-29 | 2010-11-24 | 陕西师范大学 | Gradient freeze crystallization method for polyunsaturated fatty acids from silkworm chrysalis oil |
Non-Patent Citations (4)
Title |
---|
ERKKI UKSILA等: "Crystallization of Linseed Oil Fatty Acids from Acetonitrile", 《ACTA CHEM.SCAND.》 * |
TOR-CHERN CHEN: "An Improved Fractional Crystallization Method for the Enrichment of γ-Linolenic Acid in Borage Oil Fatty Acid", 《IND. ENG. CHEM. RES.》 * |
唐君等: "一种鱼油中EPA和DHA富集的新方法", 《大连工业大学学报》 * |
杜玉锋: "脱氢乙酸的毒性及在鸡组织中消除规律的研究", 《中国优秀硕士学位论文全文数据库 农业科技辑》 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018071553A1 (en) * | 2016-10-11 | 2018-04-19 | Ingevity South Carolina, Llc | Method of separating tall oil fatty acids |
CN107418724A (en) * | 2017-04-19 | 2017-12-01 | 天津大学 | A kind of method for separating unsaturated fat acid blend in soybean oil residue aliphatic acid |
CN107602386A (en) * | 2017-08-28 | 2018-01-19 | 浙江海洋大学 | A kind of method that low temperature crystallization is enriched with ethyl esterified fish oil EPA, DHA |
CN107602386B (en) * | 2017-08-28 | 2020-08-11 | 浙江海洋大学 | A kind of method of low temperature crystallization enrichment ethyl esterification fish oil EPA, DHA |
CN111575110A (en) * | 2020-05-27 | 2020-08-25 | 嘉必优生物技术(武汉)股份有限公司 | A kind of purification method of microbial oil containing polyunsaturated fatty acid |
CN115715559A (en) * | 2022-11-08 | 2023-02-28 | 嘉必优生物技术(武汉)股份有限公司 | Method for enriching DHA in grease |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2020277148B2 (en) | Very long chain polyunsaturated fatty acids from natural oils | |
DK170227B1 (en) | Process for continuous fractionation of a mixture of fatty acids and use of a fraction enriched with gamma-linolenic acid obtained by the process | |
CN105316113A (en) | Polyunsaturated fatty acid enriching method | |
JP6899415B2 (en) | Method for Producing Concentrated Composition of C20-C22 Long Chain Polyunsaturated Fatty Acid and Concentrated Composition of C20-C22 Long Chain Polyunsaturated Fatty Acid | |
JP6423436B2 (en) | Chromatographic method for producing polyunsaturated fatty acids | |
JP2013151689A (en) | Method for producing fatty acid composition containing dha | |
KR102265636B1 (en) | Recovering urea and oil from a urea/oil complex | |
Morales-Medina et al. | Mass transfer modeling of sardine oil polyunsaturated fatty acid (PUFA) concentration by low temperature crystallization | |
Setyawardhani et al. | Separating poly-unsaturated fatty acids from vegetable oil using urea complexation: The crystallisation temperature effects | |
CN107216252A (en) | A kind of preparation method of high content Omega-3 fatty-acid ethyl esters | |
CN109438227B (en) | Production method of omega-3 polyenoic fatty acid ethyl ester | |
WO2016058282A1 (en) | Method for recycling urea in urea adduct process | |
CN111635308B (en) | Method for preparing linoleic acid and a-linolenic acid through joint production from jatropha seed oil | |
CN103951556B (en) | A distillation process for separating EPA, DPA and DHA from deep-sea fish oil | |
CN107162910B (en) | Method for preparing high-purity EPA-EE from fish oil | |
EP3294851B2 (en) | Winterization of fish oil | |
CN101429113A (en) | Method for extracting and producing alpha-eleostearic acid, its salt and ester from balsam pear | |
Zhang et al. | Concentration of DHA and EPA from marine fish oil by urea complexation | |
Rastegari et al. | Fractionation of fish waste oil through low-temperature crystallization in acetone followed by urea complexation | |
EP4289280A1 (en) | A method of efficiently separating solid fat from polyunsaturated fatty acid grease | |
US20130261326A1 (en) | Procedure for stabilising polyunsaturated fatty acids with metal hydrides | |
CN105085239A (en) | Preparation method for high purity catalpic acid and series products like ester and salt thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160210 |
|
WD01 | Invention patent application deemed withdrawn after publication |